Investing in manufacturing excellence at Hikma

Annual Report 2025
Case study

Our purpose in action Manufacturing excellence sits at the heart of Hikma’s operations. With 29 manufacturing plants across the US, Europe and the MENA region, our global production network represents a critical core strength that underpins our competitive advantage. As a global leader with local reach, we tailor production to meet the specific needs of local markets while maintaining world-class standards.

Ongoing capital investment

We have always committed significant resources to expand manufacturing facilities globally, while ensuring we maintain the highest levels of quality. By investing in our manufacturing network, we are better able to serve hundreds of millions of patients worldwide. Throughout 2025, we made substantial capital investments in manufacturing infrastructure to enhance capabilities and capacity.

Selected highlights

Columbus, Ohio, US – Expanded our Hikma Rx site to support our contract manufacturing (CMO) business, an increasingly important contributor to segment growth over the medium to long term.

Algeria – Successfully upgraded our existing facility to a fully-contained oral oncology manufacturing plant, strengthening and expanding our oncology business in Algeria.

Tunisia – Launched an updated manufacturing plant to produce general formulation medicines, expanding our capacity to serve North African patients.

Looking ahead

We remain committed to expanding our manufacturing footprint and advancing technology across our global network. In 2026, strategic investments in our injectables facilities in the US and Portugal will enhance capacity and strengthen our ability to meet growing demand in these key markets.

“Manufacturing excellence is the foundation of everything we do at Hikma. Investing into facilities worldwide enable us to combine cutting-edge technology with local expertise, delivering the high-quality medicines patients need while driving sustainable growth for our business.”

Khalid Nabilsi, Deputy CEO, North America and Europe